07.15.24 -- Select Your CDMO Based On How You Operate

This article looks at key features of restricted access barrier systems and isolators and discusses some of their applications.

Benjamin Stevens, Director CMC Policy and Advocacy at GSK provides some initial thoughts on the regulatory aspects related to moving programs to and through the clinic as quickly as possible.

Reducing risk while maximizing API volume is critical during the fill finish phase of manufacturing. To ensure safety and quality, partner with an experienced fill finish provider.

Learn how a Stage-Gate approach to technology transfer and biomanufacturing can help to mitigate risk while shortening cycle times throughout the project lifecycle.

Many small and/or early-stage companies are not aware of the need, or the possibility, of finding a CDMO that specializes in meeting their specific requirements.

A commercial packaging solution can be the first and enduring impression that a sponsor company makes on a patient, and its suitability can impact a biologic’s commercial success.

Uncover the latest trends in cell culture technology, tools and enablers for scale-up, strategies to accelerate CLD, media development, raw material characterization, and more.

Explore the ways to design and de-risk molecules, streamlining the path to GMP manufacturing and clinical trials, and case studies that provide insight into key activities.

Learn about the benefits of microfluidics for nanoparticle production over traditional methods as well as scaling nanoparticle production for clinical or industrial use.

For biopharmas looking to outsource their early phase development, consider working with a CDMO partner that has the knowledge and experience to navigate microbial fermentation and complex process development.

Explore continuous models of k_La and P/V in 250mL and 5L bioreactors in order to scale-up and compare bioreactor performance metrics.

Our scientists offer insights into physicochemical and structural properties, including post-translational modifications, through a range of assays.

Learn how INCOG BioPharma's speed and flexibility can help your organization with your drug product, from clinical to commercial, with our high-performing cleanroom facility and filling technology.

Examine how a new high-speed aseptic filling line can help bring your product to market with speed and efficiency while ensuring safety and high product quality.